Operational Feasibility of Appropriate Radical Cure of Plasmodium Vivax With Tafenoquine or Primaquine After Quantitative G6PD Testing in Brazil

NCT05096702 · clinicaltrials.gov ↗

UNKNOWN

Status

16000

Enrollment

OTHER

Sponsor class

Conditions

Malaria, Vivax
G6PD Deficiency

Interventions

DRUG: Tafenoquine
DRUG: Primaquine
DRUG: Primaquine

Sponsor

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]